Kaohsiung Medical University Hospital, Taiwan Background and Aims: COPD (chronic obstructive pulmonary disease) is aware as a global health problem increasingly and statistically it affects more than 300 million patients in the world. Monocytes recruitment to the lungs is also an important step in COPD. The pulmonary macrophages in COPD smokers are resulted from monocytes as a response to the chemotactic chemokines. PDE4 inhibitors play the roles in airway smooth muscle relaxation and inflammatory cells activation inhibition.
Methods:
The CCL-1, CCL-2 and IP-10 concentrations of the cell supernatants were measured using commercially available ELISA assay (R & D system, Minneapolis, MN) following the manufacturer's instruction.
Results: Following the stimulation of LPS, TLR4 mediates CCL-1 and CCL-2 through the MAPKs and NFκB pathway. Also, the epigenetic modification of H3 is also involved in their secretions. Rolipram, a PDE4 inhibitor, inhibits the PDE4 activity which leads to cAMP accumulation inside cells following PKA activation. Following the stimulation of LPS, TLR4 mediates CCL-1 and CCL-2 through the MAPKs and NFκB pathway. Also, the epigenetic modification of H3 is also involved in their secretions. Rolipram, a PDE4 inhibitor, inhibits the PDE4 activity which leads to cAMP accumulation inside cells following PKA activation.
Conclusion:
In conclusion, our results provided an exciting data that Rolipram inhibited LPS induced CCL-1 (I309)/CCL2 expression via MAPKs and epigenetic modifications. Further study into the possible candidates in COPD treatment or other cytokines/chemokines in COPD pathogenesis might be necessary. Background and Aims: Hypoxia-inducible factor (HIF)-1α signaling was activated during cigarette smoke (CS)-induced chronic obstructive pulmonary disease (COPD). Tanshinone IIA was reported to be able to inhibit HIF-1α expression in LPS-induced lung injury. This present study aimed to investigate the effects of sodium tanshinone IIA sulfonate (STS), a water-soluble derivative of tanshinone IIA, on CS-induced COPD in mice and the underlying mechanisms.
Methods: The role of STS in cigarette smoke extract (CSE)-induced inflammation, oxidative stress was investigated using RAW 264.7 cells. The in vivo effects of STS were evaluated in a mouse model of CSinduced COPD.
Results: Here, we found that STS improved pulmonary function, ameliorated emphysema and decreased the infiltration of inflammatory cells in the lungs of CS-exposed mice. STS reduced CS-and CSEinduced upregulation of tumour necrosis factor (TNF)-α and interleukin (IL)-6 in the lungs and macrophages. STS also inhibited CSE-induced reactive oxygen species (ROS) production, as well as the upregulation of heme oxygenase (HO)-1, matrix metalloproteinase (MMP)-9 and MMP-12 in macrophages. In addition, STS suppressed HIF-1α expression in vivo and in vitro, and pretreatment with HIF-1α siRNA reduced CSEinduced elevation of TNF-α, IL-6 and HO-1 content in the macrophages. Moreover, we found that STS inhibited CSE-induced AKT phosphorylation in macrophages, and inhibition of this signaling molecule significantly repressed CSE-induced TNF-α, IL-6, HO-1 and HIF-1α expression. It indicated that STS inhibits CSE-induced HIF-1α expression likely by blocking AKT signaling. Furthermore, STS also promoted HIF-1α protein degradation in CSE-stimulated macrophages. Background and Aims: VATS is commonly performed in children with empyema, however, there is no data regarding the post-operative outcomes (after discharge) following the procedure.
Conclusion

Methods:
A 5-year (2013-2018) retrospective review was performed on children treated with VATS and chest drain for empyema. The study was approved by the local ethics committee (RES-18-0000-071Q). Statistics: results are reported as number of cases (%) and median (range). Correlation and logistic regression analysis were performed.
Results: We identified 62 children, 36 (58%) males, with a median age of 3.6 (0.4-14.5) years treated over the 5-year period. Presentation was: autumn 12 (19%), winter 19 (31%), spring 19 (31%) and summer 12 (19%) patients. Median post-operative follow-up was 47 (9-489) days.
Streptococcus species were identified in 35 (56%) of cultures from pleural fluid. Chest drain was left in situ for a median of 4 (2-13) days.
Four (6%) children required a second procedure (3 VATS, 1 thoracotomy).
